Search

everythinglearnresearchcommunity

for

Search:↓

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Reflectance confocal microscopy confirms that yellow dots are signs of damaged hair follicles in alopecia areata.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Obesity and lifestyle strongly affect heart aging.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

New techniques for treating scalp blood vessel malformations are effective and can have good cosmetic results.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.